These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 8322770)

  • 1. Immunoglobulin A-fibronectin aggregate levels in children and adults with immunoglobulin A nephropathy.
    Baldree LA; Wyatt RJ; Julian BA; Falk RJ; Jennette JC
    Am J Kidney Dis; 1993 Jul; 22(1):1-4. PubMed ID: 8322770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uteroglobin interacts with the heparin-binding site of fibronectin and prevents fibronectin-IgA complex formation found in IgA-nephropathy.
    Chowdhury B; Zhang Z; Mukherjee AB
    FEBS Lett; 2008 Mar; 582(5):611-5. PubMed ID: 18243143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Transcriptional Analysis of IgA Vasculitis, IgA Nephropathy, and IgA-Dominant Infection-Related Glomerulonephritis Reveals Both Distinct and Overlapping Immune Signatures.
    Kung VL; Avasare R; Friedman MA; Koon SM; Neff TL; Protzek S; Corless C; Krajbich V; Setthavongsack N; Ditmore R; Woltjer R; Andeen NK
    Kidney360; 2023 Jun; 4(6):e759-e768. PubMed ID: 37036681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell RNA sequencing of pediatric renal tissues revealed the potential relationship between immunoglobulin A nephropathy and immunoglobulin A vasculitis with nephritis.
    Ye Q; Meng H; Ye F; Fu H; Wang J; Liu F; Shen H; Bao Y; Feng C; Zhang X; Huang G; Xie Y; Zhu X; Zhao M; Guo G; Mao J
    Clin Transl Med; 2024 Apr; 14(4):e1651. PubMed ID: 38591641
    [No Abstract]   [Full Text] [Related]  

  • 5. APRIL - Springtime for New IgA Nephropathy Therapy?
    Lemley KV; Glassock RJ
    N Engl J Med; 2024 Jan; 390(1):80-81. PubMed ID: 38169494
    [No Abstract]   [Full Text] [Related]  

  • 6. Selecting Treatment for IgA Nephropathy.
    McGuire M
    Clin J Am Soc Nephrol; 2023 Sep; 18(9):1109-1110. PubMed ID: 37553878
    [No Abstract]   [Full Text] [Related]  

  • 7. Considering the Treatment of IgA Nephropathy.
    Lafayette RA; Kamal FS
    Clin J Am Soc Nephrol; 2023 Sep; 18(9):1113-1115. PubMed ID: 37533148
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeting APRIL in the Treatment of IgA Nephropathy.
    Cheung CK; Barratt J; Carroll K; Lafayette RA; Liew A; Suzuki Y; Tesař V; Trimarchi H; Wong MG; Zhang H; Perkovic V; Rizk DV
    Clin J Am Soc Nephrol; 2024 Mar; 19(3):394-398. PubMed ID: 37801688
    [No Abstract]   [Full Text] [Related]  

  • 9. Uncovering Rare Coding Variants in IgA Nephropathy.
    Liu J; Xie J
    J Am Soc Nephrol; 2023 Nov; 34(11):1769-1771. PubMed ID: 37759350
    [No Abstract]   [Full Text] [Related]  

  • 10. Reconstructing the interface between the human intestine and immune system: potential to advance mechanistic studies in IgA nephropathy.
    Wang H; Zuiani J; Coates Ao PT; Xia Y
    Kidney Int; 2024 Mar; 105(3):423-426. PubMed ID: 38388138
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating Proteins and IgA Nephropathy: A Multiancestry Proteome-Wide Mendelian Randomization Study.
    Tang C; Chen P; Xu LL; Lv JC; Shi SF; Zhou XJ; Liu LJ; Zhang H
    J Am Soc Nephrol; 2024 Aug; 35(8):1045-1057. PubMed ID: 38687828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid therapy is effective for IgA nephropathy after liver transplantation in a pediatric patient.
    Tamura H; Kuraoka S; Nakazato H
    Clin Case Rep; 2021 May; 9(5):e04237. PubMed ID: 34026195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Incidence of IgA Nephropathy by Race and Ethnicity: A Systematic Review.
    Kiryluk K; Freedberg DE; Radhakrishnan J; Segall L; Jacobson JS; Mathur M; Mohan S; Neugut AI
    Kidney360; 2023 Aug; 4(8):1112-1122. PubMed ID: 37227924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is it time for personalized therapy in IgA nephropathy patients?
    Schena FP; Cox SN
    J Nephrol; 2023 Nov; 36(8):2171-2173. PubMed ID: 37737956
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of Telitacicept in patients with IgA nephropathy.
    Liang D; Li X
    Pak J Med Sci; 2023; 39(6):1897. PubMed ID: 37936774
    [No Abstract]   [Full Text] [Related]  

  • 16. Correction to: Is it time for personalized therapy in IgA nephropathy patients?
    Schena FP; Cox SN
    J Nephrol; 2024 Jan; 37(1):257. PubMed ID: 38064147
    [No Abstract]   [Full Text] [Related]  

  • 17. Corticosteroids in Patients With IgA Nephropathy: Is the Lower the Better?
    Rauen T; Vogt K; Seikrit C
    Kidney Int Rep; 2024 Jul; 9(7):1966-1968. PubMed ID: 39081733
    [No Abstract]   [Full Text] [Related]  

  • 18. EXternal validation of international IgA nephropathy prediction tool in a Singapore CohorT (EXIST Study).
    Lim RS; Yeo SC
    J Nephrol; 2024 Jun; ():. PubMed ID: 38869822
    [No Abstract]   [Full Text] [Related]  

  • 19. Podocyte puzzle: IgA nephropathy.
    Bharati J; Munir K; Jhaveri KD
    Clin Kidney J; 2023 Dec; 16(12):2760-2761. PubMed ID: 38046010
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.